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Summary
Objective: To elucidate disease-speciﬁc molecular changes in osteoarthritis (OA) by analyzing the differential gene expression proﬁle of dam-
aged vs intact cartilage areas within the same joint of patients with OA of the knee using a combination of a novel RNA extraction technique
and whole-genome oligonucleotide arrays.
Methods: The transcriptome of macroscopically affected vs intact articular cartilage as determined by visual assessment was analyzed using
an optimized mill-based total RNA isolation directly from the tissue and high density synthetic oligonucleotide arrays. Articular cartilage sam-
ples were obtained from patients with OA of the knee. Expression of differentially regulated genes was validated by real-time quantitative poly-
merase chain reaction and immunohistochemistry.
Results: The amount of RNA obtained by the optimized extraction procedure was at least 1 mg per 500 mg of cartilage and fulﬁlled the com-
mon quality requirements. After hybridization onto HG-U133 Plus 2.0 GeneChips (Affymetrix), 28.6e51.7% of the probe sets on the microarray
showed a detectable signal above the signal threshold in the individual samples. A subset of 411 transcripts, which appeared to be differen-
tially expressed, was obtained when applying predeﬁned ﬁltering criteria. Of these, six genes were found to be up-regulated in the affected
cartilage of all patients, including insulin-like growth factor binding protein 3 (IGFBP-3), wnt-1-inducible signaling protein 1 (WISP-1), aquaporin
1 (AQP-1), delta/notch-like EGF-repeat containing transmembrane (DNER), decay accelerating factor (DAF), complement factor I (IF).
Conclusion: The optimized methodical approach reported here not only allows to determine area-speciﬁc gene expression proﬁles of intrain-
dividually different low-RNA containing OA cartilage specimens. In addition, this study also revealed novel genes not yet reported to play a role
in the pathophysiology of joint destruction in OA.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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phosphate dehydrogenase, RT-PCR reverse transcription polymerase chain reaction.Introduction
Being the most frequently diagnosed disorder of the musk-
uloskeletal system1,2, osteoarthritis (OA) is a multifactorial,
slowly progressing and primarily non-inﬂammatory degen-
erative joint disease. It does not only include cartilage alter-
ations but also pathological changes in other joint*Address correspondence and reprint requests to: Matthias
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328compartments including subchondral bone, synovial tissue,
the joint capsule, ligaments and periarticular muscles3,4.
Owing to the developments in microarray technology,
which enabled to draw a more concise picture of functional
genomics not only in OA, at present, a large variety of
genes and their products are known to play a role in OA
pathophysiology5e9. However, large amounts of pure and
intact RNA are necessary when applying array techniques,
and due to the very low cellular content of cartilage, the ex-
traction of RNA from human articular cartilage faces numer-
ous obstacles, speciﬁcally with regard to an adequate yield
for further experiments. This problem often forces re-
searchers to isolate cells out of the tissue before extracting
the RNA, but leaves the problem of potential alteration of
gene expression when processing the cells unanswered.
329Osteoarthritis and Cartilage Vol. 17, No. 3Quantitative limitations may also be one of the reasons
for the scarcity of data addressing alterations in gene ex-
pression in distinct areas within the same OA joint, espe-
cially for the comparison of damaged and intact regions of
the cartilage9e11. In these experimental settings, mainly
pooled RNA of diseased and healthy cartilage of different
individuals was used to analyze differential gene expres-
sion which could not determine disease-speciﬁc pathways
in a single individual5e8.
Using a novel mill-based RNA isolation technique in com-
bination with high-density oligonucleotide array analysis, we
investigated the differential gene expression pattern of
chondrocytes localized within an OA lesion vs an unin-
volved part of OA cartilage of the same joint on a ge-
nome-wide range. We directly processed the tissue
avoiding an enzymatic tissue digestion, pooling of samples
and two-round in vitro transcription ampliﬁcation. Validation
of our microarray results was performed by real-time quan-
titative polymerase chain reaction (PCR) and
immunohistochemistry.
Patients, materials and methodsTISSUE PREPARATIONFig. 1. Swing mill (microdismembrator) used for cartilage prepara-
tion (A). The individual cartilage tissue samples were pulverizedCartilage samples were obtained from complete knee joint explants from
patients with OA undergoing routine total joint replacement surgery. The
study had been approved by the local Ethics Committees and specimens
were taken with patients’ written consent. Samples were either used for mi-
croarray analysis (one male age 64, and four female patients age 59, 71, 73
and 83), validation experiments by quantitative PCR (one male age 55, and
four females age 65, 73, 76 and 83) or immunohistochemistry (one male age
61, and two females age 73 and 78). Prior to RNA isolation, cartilage tissue
was ﬁrst classiﬁed macroscopically as either damaged or intact according to
a predeﬁned procedure comprising color, surface integrity and tactile impres-
sion tested with a standard scalpel. Accordingly, diseased areas showed
a coloration that was rather yellow than white. They showed erosions and
discrete protuberances that rendered it impossible to smoothly move the
scalpel over the tissue surface. In unaffected regions there was a stronger
resistance when cutting deeper into the tissue with the blade of the scalpel,
which could not be done in the softened lesional areas. Cartilage was rinsed
with saline and then dissected from the joint explant surfaces. Care was
taken to avoid contamination by blood, bone or synovium. The tissue was
cut into small pieces, immediately snap frozen and stored at 80C until fur-
ther use. For later histological examination, representative pieces of every
region were embedded in Tissue-Tek, frozen in liquid nitrogen and also
stored at 80C until further use.with steels balls in steel cases (B) double-ﬁxed in the mill (A) with
a safety screw. The pre- (C) and post-pulverization (D) status is
shown schematically.RNA EXTRACTIONTo optimize RNA extraction, we evaluated different mechanical tissue dis-
ruption strategies including mortar and pestle, a statorerotor homogenizer
such as the polytron, a freezer mill and a microdismembrator. We also eval-
uated different isolation procedures including the Trizol method and silica
membrane-based commercial extraction kits such as the RNeasy spin col-
umns (Qiagen, Hilden, Germany) or glass ﬁber ﬁlters (Ambion, Austin, TX,
USA). The optimal protocol consisted of pulverization of frozen tissue sam-
ples at 2500 rpm for 2 min under continuous cryoconditions (below 18C)
with a steel ball in steel cases (both pre-cooled in liquid nitrogen for several
minutes) using a swing mill, the microdismembrator (Mikrodismembrator S,
Braun, Melsungen, Germany; Fig. 1). Thereafter, a commercial extraction
kit (RNAqueous-Midi, Ambion) was used to isolate total RNA from the re-
sulting cartilage powder. The isolation procedure was adapted to the very
low RNA containing OA cartilage tissue conditions by modifying the manu-
facturer’s protocol as follows.
Initially, 6.5 ml of lysis solution containing guanidinium isothiocyanate (GITC)
were added to 500 mg of freshly milled cartilage that had been transferred to
50 ml reaction tubes, which were also pre-cooled in liquid nitrogen. The suspen-
sion was then mixed by strongly shaking the tube up and down until complete
homogenization was achieved. Thereafter, the suspension was incubated at
4C overnight. Afterward, the lysate was centrifuged at 5000g and 4C for
10 min. The clear supernatant was transferred to a fresh tube of equal size by
passing the solution through a 70 mmnylon cell ﬁlter in order to completely elim-
inate the rest of debris and to prevent glass ﬁber ﬁlter clogging. The procedure
was completed then as indicated in the instruction manual (Ambion).
After recovery of the RNA, standard ethanol precipitation and DNase di-
gestion were applied: 0.1 volume of 5 M ammonium acetate, 0.01 volume
of Glycoblue (both Ambion, Austin, TX, USA) and two volumes of ice-cold100% ethanol were added to the eluates. After gentle mixing, they were in-
cubated at 20C overnight and then centrifuged at 12100g for 15 min using
a miniSpin table centrifuge (Eppendorf, Germany) to pellet the precipitated
RNA. After washing the pellet with ice-cold 70% (v/v) ethanol it was resolved
in the respective volume of nuclease-free water pre-heated to 65C, usually
10e20 ml. DNase digestion was performed according to the manufacturer’s
instructions using the TURBO DNA-free Kit (Ambion).
RNA yields were quantiﬁed spectrophotometrically measuring its absor-
bance (A) at a wavelength of 260 nm. Qualitative assessment of RNA integ-
rity was performed by taking the A260/280 ratio as well as doing RNA 6000
Nano Assays on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA), respectively. During the evaluation phase, RNA quality
was also analyzed on 0.8% denaturating agarose gels containing
formaldehyde.HIGH-DENSITY SYNTHETIC OLIGONUCLEOTIDE ARRAY
HYBRIDIZATIONThe individual chondrocyte RNA samples were used to synthesize cDNA
that was in vitro transcribed into biotin-labeled cRNA. Fragmented cRNA
was then hybridized to microarrays (Affymetrix HG-U133 Plus 2.0 Arrays,
Center of Excellence for Fluorescent Bioanalysis, Regensburg, Germany) fol-
lowing standard Affymetrix protocols using the MessageAmp II-Biotin En-
hanced Kit (Ambion). Finally, 15 mg of the fragmented cRNA were
hybridized to the GeneChips, washed and stained with the streptavidinephy-
coerythrin complex. Signal intensity images were acquired by scanning the
330 M. Geyer et al.: Differential transcriptome analysis of intraarticular lesional vs intact cartilagearrays with a GeneChip Scanner 3000 following standard protocols (Affyme-
trix , Santa Clara, CA, USA).DATA ANALYSISLow-level analysis including background correction and qualitative experi-
ment evaluation by checking internal controls as well as calculating expres-
sion values for all genes on all arrays were performed using the GeneChip
Operating Software 1.2 with its MAS5 algorithm (Affymetrix). The arrays
were normalized by global scaling the mean array intensities to a target inten-
sity value of 100. Lesional chondrocyte gene expression arrays were com-
pared to their corresponding baseline arrays of non-lesional regions in order
to obtain a patient-speciﬁc pairwise ‘‘chip-by-chip’’ analysis of differential
gene expression. Using MS Excel for the identiﬁcation of genes of interest,
we then focused on all transcripts that were regulated in the same direction
(up- or down-regulated) according to their change calls for increase (I) or de-
crease (D) in at least three of the ﬁve patients and that did not show nonsense
detection calls. Therefore, genes had to be called as present in at least base-
line or experiment array, and up-regulated genes showing absent calls in the
experiment array as well as down-regulated genes called absent in the base-
line array had to be excluded12. The statistical algorithms for calculating these
parameters, i.e., change calls and detection calls, as well as to indicate signal
log ratios (SLRs), were applied according to the software manual descrip-
tions13. An SLR is deﬁned as the dyadic logarithm of a fold change.REAL-TIME QUANTITATIVE PCRGene expression results of those genes found to be up-regulated in all
ﬁve patients were validated by real-time quantitative PCR, applying the
DDCt relative quantiﬁcation method and using glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as an internal control. Puriﬁed RNA was reversely
transcribed into cDNA using Superscript II RT (Invitrogen, Karlsruhe, Ger-
many). Equivalent amounts as calculated by the initial RNA quantity were
added to the reaction mix including 12.5 ml SYBR Green (Applied Biosys-
tems, Foster City, CA, USA), forward and reverse primer (10 pmol/ml),
0.5 ml each (MWG-Biotech, Ebersberg, Germany) and nuclease-free water
to ﬁnal volumes of 25 ml per well. Primer sequences are listed in Table I.
Real-time PCRs were run in an ABI Prism 7000 Sequence Detection System
(SDS) using the ABI Prism 7000 SDS software version 1.2.3.IMMUNOHISTOCHEMISTRYIce-cold acetone-ﬁxed cryosections (5 mm) were used to perform immuno-
histochemistry. Sections were ﬁrst blocked with 5% low-fat milk for 60 min at
room temperature followed by incubation with the primary antibodies (goat
polyclonal anti-WISP-1, 1:5 dilution, R&D Systems, goat polyclonal anti-
DAF, 1:40 dilution, R&D Systems, or mouse monoclonal anti-AQP-1 anti-
bodies, 1:100 dilution, Biozol, Eching, Germany), followed by peroxidase
blocking with 0.6% H2O2 in methanol for 30 min at 4
C. Immunoreactivity
was detected using labeled polymers prepared by combining amino acid
polymers with peroxidase and secondary antibodies reduced to Fab frag-
ments (N-Histoﬁne simple Stain MAX PO (G) anti-goat and MAX PO (MULTI)
anti-mouse) for 30 min at room temperature, followed by color developmentTable I
Primer sequences for qRT-PCR
Gene Pimer sequence Amplicon
size (bp)
IGFBP-3 f 50-TCT GCG TCA ACG CTA GTG C-30 245
r 50-GCT CTG AGA CTC GTA GTC AAC T-30
WISP-1 f 50-CCA GCC TAA CTG CAA GTA CAA-30 160
r 50-GGC GTC GTC CTC ACA TAC C-30
AQP-1 f 50-GGT GGG GAA CAA CCA GAC G-30 177
r 50-TAC ATG AGG GCA CGG AAG ATG-30
DNER f 50-AAG GCT ATG AAG GTC CCA ACT-30 137
r 50-CTG AGA GCG AGG CAG GAT TT-30
DAF f 50-CTT CCC CCA GAT GTA CCT AAT GC-30 184
r 50-CGC AGC TAC GAT TGC AGA ACT-30
IF f 50-TGG CAG GTG GCA ATT AAG GAT-30 111
r 50-ACG ATG AGT TTT ACT GGC TCT G-30
GAPDH f 50-CTG ACT TCA ACA GCG ACA CC-30 120
r 50-CCC TGT TGC TGT AGC CAA AT-30using 3-amino-9-ethylcarbazole substrate (AEC substrate kit, Axxora, San
Diego, CA, USA). The sections were counterstained with Meyer’s hematox-
ylin for 10 min and then mounted with Aquatex (Merck, Darmstadt, Ger-
many). Negative controls were obtained by omitting the primary antibodies
or by incubating the tissue sections with irrelevant isotype-matched normal
IgG (goat: Santa Cruz Biotechnology, Heidelberg, Germany; mouse: BD
Pharmingen, Heidelberg, Germany). Sections were examined under a light
microscope and photographed with a digital camera.ResultsAMOUNTS OF TOTAL RNA AND INTEGRITYUsing the adapted and optimized RNA isolation proce-
dure, stable amounts of total RNA of at least 1 mg per
500 mg OA cartilage could be obtained. However, it could
be more total RNA depending on the quality of the tissue
specimen. The A260/280 ratio resulted in values between
1.6 and 2.0, indicating the lack of a relevant contamination
in the samples. Graphical analysis on the Agilent Bioana-
lyzer constantly showed clearly visible peaks for both 28S
and 18S ribosomal RNA demonstrating that RNA degrada-
tion during the downstream applications was minimal. A
representative electropherogram is given in Fig. 2.
Table II summarizes the results of different RNA isolation
approaches that have been evaluated during the optimiza-
tion process. Among these, different mechanical tissue dis-
ruption strategies comprising a rotorestator homogenizer
such as the polytron, a common mortar and pestle and
a swing mill (microdismembrator) were used and compared.
The RNA isolation was performed using the Trizol method,
all available package sizes of Qiagen’s RNeasy spin col-
umns ranging from mini over midi to maxi, and ﬁnally Am-
bion’s glass ﬁlter membranes, also provided in different
package sizes. RNA of same amounts of tissue was iso-
lated and yields after isolation were compared.
Pretreatment with the polytron and in the microdismem-
brator was done in lysis buffer at room temperature. So
far, it was impossible to homogenize the tissue. Disruptions
with mortar and pestle and again within the microdismem-
brator were performed under cryoconditions using liquid ni-
trogen. It became clear that the mechanical properties of
articular cartilage made it necessary to use a closed system
to disrupt the tissue with stronger forces in its frozen form,
which resulted in higher amounts of total RNA with integrity,
independent of the RNA isolation strategy itself. However,
the membrane-based methods (Qiagen and Ambion kits)
were superior to the common and widely used Trizol
method where the RNA was degraded. As the swing mill
obtained the best pretreatment results, the RNA extraction
was compared using the Qiagen and Ambion kits. The Am-
bion kit resulted in the highest amounts of good-quality
RNA. For tissue RNA isolation, especially human articular
cartilage, combination and evaluation of different options re-
sulted in deﬁnite differences with regard to the amount and
quality of total RNA obtained by these approaches. Of note,
we did not observe any of the differences described herein
when working with cells.MICROARRAY RESULTS AND DIFFERENTIALLY EXPRESSED
GENESIn general, between 28.6% and 51.7% of the 54,675
probe sets on the oligonucleotide array were detectable,
with an average of 43% (median 47.7%). In the intact areas,
an average of 43.1% (median 49.8%) vs an average of
42.9% (median 45.6%) in the affected regions could be
detected.
Fig. 2. Graphical analysis of the RNA integrity on the Agilent 2100 Bioanalyzer. The electropherogram shows clear peaks for both 28S and
18S rRNA. Although there is a slight decrease in height of the 28S rRNA peak, RNA quality can be considered as high.
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Probe Sets for 411 transcripts, 342 of which could be con-
sidered as known genes. Of these, six genes were up-reg-
ulated in all ﬁve patients in the diseased areas, 36 genes in
four of, and 159 genes in three of the ﬁve patients. Interest-
ingly, no gene was found to be down-regulated in diseased
cartilage of all ﬁve patients, however, 14 genes were down-
regulated in 4/5 patients and 127 genes in 3/5 patients.
The genes identiﬁed to be up-regulated in all ﬁve patients
were insulin-like growth factor binding protein 3 (IGFBP-3),
wnt-1 inducible signaling protein 1 (WISP-1), aquaporin 1
(AQP-1), delta/notch-like EGF-repeat containing transmem-
brane (DNER), decay accelerating factor (DAF, CD55) and
complement factor I (I factor for complement, IF). Affymetrix
probe set IDs, names, short names, the mean SLR and the
mean change P-value (CPV) of the six genes found to be
up-regulated in all ﬁve patients are listed in Table III.RESULTS BY REAL-TIME QUANTITATIVE PCRReal-time quantitative PCR was performed on the six up-
regulated genes in order to validate the microarray results.
We used the RNA of ﬁve additional pairs of affected and in-
tact cartilage tissue specimens to determine whether there
were any differences between both techniques. We found
that consistent with the microarray data, expression of the
genes was signiﬁcantly different between both regions.Table II
RNA yield and quality obtained by different isolation approaches
Mechanical pretreatment Extraction procedure
Trizol Qiagen Ambion
Polytron n.d. þ n.d.
Mortar and pestle n.d. þ n.d.
Mill deg. þþ þþþ
þ (Low): <50 ng/ml; þþ (medium): 50e100 ng/ml; þþþ (high):
>100 ng/ml; n.d.¼ not determined; deg.¼ degraded.Representative results of one patient are given in Fig. 3,
which also demonstrates that the x-fold change in gene ex-
pression monitored by quantitative PCR was higher than
that obtained by using the microarrays.IMMUNOHISTOCHEMISTRYTo conﬁrm the up-regulation of the genes found in the ol-
igonucleotide array in lesional areas in OA cartilage on
a protein level, immunohistochemistry was performed using
commercially available antibodies against AQP-1, WISP-1
and DAF. As demonstrated in Fig. 4, the increased expres-
sion of AQP-1 in damaged tissue was restricted to chondro-
cytes in the superﬁcial areas (Fig. 4E) whereas WISP-1 was
increasingly expressed by chondrocytes throughout the af-
fected cartilage (Fig. 4I and K). The increased staining
against DAF occurring in the affected areas compared to in-
tact cartilage also tended to be more prominent at the su-
perﬁcial site of the cartilage (Fig. 4N and O).Discussion
OA is regarded a very complex and multifactorial dis-
ease14, which is based on a variety of dysregulated path-
ways. However, its pathogenesis still needs to be
elucidated in detail, especially when focusing on the molec-
ular level. For the investigation of its complex pathophysiol-
ogy, articular cartilage containing the key cells in the
pathophysiology of OA, the chondrocytes, appears to be
a perfect type of biological material because of its availabil-
ity from routine joint replacement surgery.
However, the extraction of RNA out of cartilage is still
a challenge for all researchers working in that ﬁeld due to
its distinct composition. With only between 1% and 5% of
the tissue volume, cartilage has a very low cellular content
of chondrocytes surrounded by a very large amount of ex-
tracellular matrix. The matrix itself contains large and nega-
tively charged macromolecules, which interfere signiﬁcantly
Table III
Genes identified to be up-regulated in all five patients (alphabetical order)
Probe set ID Gene name Symbol Mean SLR Mean CPV
209047_at Aquaporin 1 (channel-forming integral protein, 28 kDa) AQP-1 1.38 0.0000948
1555950_a_at Decay accelerating factor for complement (CD55, Cromer blood group system) DAF 0.92 0.0000538
226281_at Delta-notch-like EGF repeat-containing transmembrane DNER 1.16 0.0000468
203854_at I factor (complement) IF 1.14 0.0001440
210095_s_at Insulin-like growth factor binding protein 3 IGFBP-3 1.60 0.0000440
229802_at WNT-1 inducible signaling pathway protein 1 WISP-1 0.98 0.0000372
332 M. Geyer et al.: Differential transcriptome analysis of intraarticular lesional vs intact cartilagewith the RNA extraction process. In the current literature,
only a small number of publications exists that address
how to potentially overcome this speciﬁc problem of RNA
isolation out of cartilage by means of a suitable technical
approach. Most of these studies were performed on the ba-
sis of animal tissues, i.e., of chicks15, rats16, dogs17 or rab-
bits18, which in general have a higher cellular content than
the corresponding human tissues, even more when working
with immature animals. Only few, single publications pro-
vide data performed with human samples19e21. The key
problem in this setting is the difﬁculty to isolate sufﬁcient
amounts of high-quality RNA that can be used for a ge-
nome-wide transcription proﬁling with high-density synthetic
oligonucleotide arrays as close as possible to the in vivo sit-
uation. In addition, as the quality of tissue samples differs
between individuals, the respective tissue specimens can
often not be used for the extraction of RNA despite a mini-
mum of delay between surgery and the use in the
laboratory.
Thus, the aim of this study was to establish a novel ap-
proach to improve the quality of RNA extraction and to
use this approach to identify novel molecules potentially
involved in the pathophysiology of human OA. The RNA
isolation technique immediately after surgery consisted of
pre-treating the freshly frozen cartilage samples by pulveriz-
ing them with a steel ball in steel cases ﬁxed in a swing mill
followed by the isolation of RNA according to an adapted
procedure based on a commercial RNA extraction kit. Using
our optimized procedure, we were able to isolate the RNA
of chondrocytes with satisfying high yield and quality. Sub-
sequently, we were able to investigate the differential gene
expression of lesional and intact zones of native human OA
cartilage, avoiding the difﬁculties of the interpretation of0
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Fig. 3. Representative results of a quantitative RT-PCR. Intensity of
differential expression is indicated as the logarithm base 2 of the
fold change. RQ: relative quantiﬁcation, equal to fold change.gene array data generated by pooling samples of different
genetic background.
Validation of our results was facilitated by quantitative
PCR as well as by examination of the corresponding pro-
teins in other OA samples by immunohistochemistry. Apply-
ing this strategy, several novel genes hitherto not known to
be involved in the pathogenesis of OA were identiﬁed. In to-
tal, 201 genes were found to be up-regulated within the le-
sional areas of OA cartilage vs 141 genes considered to be
down-regulated when ﬁltering the gene expression data ac-
cording to the abovementioned criteria. Only six genes were
found to be up-regulated within the lesional area of all ex-
amined patients but not in non-lesional cartilage. Particu-
larly, WISP-1 and AQP-1 have not been previously linked
to the imbalance of damage and repair in OA, whereas
IGFBP-3 and DAF have been reported earlier (see the ref-
erences under Discussion).
IGFBP-3 is a binding protein (BP) for insulin-like growth
factors (IGFs). The expression of IGFBP-3 has been re-
ported to be increased in OA when compared to healthy
cartilage22. It has been stated that IGFBP-3 may inhibit
growth by binding local IGF-I23. IGFBPs maintain local
availability of IGF. IGFBP-3 was also found to form a com-
plex together with ﬁbronectin and to retain IGF-I in the peri-
chondrocytic matrix24. Thus, locally produced IGFBPs
appear to act as autocrine and/or paracrine regulators of
IGF activity both in a positive and negative manner. More-
over, the increased production of IGFBP-3 may not only
be explained by the inﬂuence of ﬁbronectin fragments25,
but also by inﬂammatory cytokines such as interleukin-1
(IL-1) and Tumor necrosis factor alpha (TNF-a)26 as well
as by prostaglandin E227 which also can up-regulate
IGFBP-3. Most interestingly, binding of IGF-I to IGFBP-3
was successfully inhibited by NBI-31772 in rabbit and hu-
man chondrocytes in vitro, resulting in restoration of proteo-
glycan synthesis28. IGFBP-3 might therefore be a target for
a pharmacological intervention in OA, although NBI-31772
itself is not able to penetrate into the matrix of the explanted
cartilage samples28.
WISP-1 is a member of the Connective tissue growth fac-
tor, Nephroblastoma overexpressed (CCN) family of growth
factors29. With regard to the musculoskeletal system,
WISP-1 exerts an important contribution to bone develop-
ment. French et al. could show that WISP-1 functions as
an osteogenesis potentiating factor promoting mesenchy-
mal cell proliferation while repressing chondrocytic differen-
tiation in vitro30. This property could also be demonstrated
in fracture healing in a mouse fracture repair model30. In
2006, the expression of full-length WISP-1 mRNA as well
as of two variants were reported in a human chondrosar-
coma-derived chondrocytic cell line, HCS-2/831. The role
of WISP-1 in chondrocyte differentiation appeared to be
more speciﬁc to the mineralizing stage of enchondral ossi-
ﬁcation31. Taking into account that WISP-1 is also ex-
pressed by OA chondrocytes in vivo as outlined above,
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Fig. 4. Illustration of representative cartilage sections within the same joint of OA patients (ﬁrst panel: original magniﬁcation 100; subsequent
panels: original magniﬁcation 200). The ﬁrst panel shows an intact area (left, A) and a diseased area (right, B) stained by hematoxylineeosin.
The second panel shows the lack of expression of AQP-1 in non-lesional areas of an OA patient (C, phase contrast D), whereas the majority of
chondrocytes in the superﬁcial zone of anOA lesion express intensively AQP-1 ([, E, phase contrast F). Similarly,WISP-1 is expressed through-
out the areas of cartilage erosions ([, I and K), whereas in intact cartilage, no speciﬁc staining (G and H) can be detected. This is also visible for
DAF.Here, an increasedstaining is to beobserved in lesional areas ([, N andO) in contrast to unaffectedcartilage (L andM).Note that forWISP-1
(third panel, H and K) and DAF (fourth panel, M and O) counterstaining with Mayer’s hematoxylin was performed to detect the nuclei of the chon-
drocytes. The inserts in K and O show a larger image of single counter-stained chondrocytes expressingWISP-1 (K) and DAF (O), respectively.
Black and white scale bars always indicate 100 mm.
334 M. Geyer et al.: Differential transcriptome analysis of intraarticular lesional vs intact cartilagethe data suggest that WISP-1 might be involved in the ossi-
ﬁcation of cartilage contributing to the formation of a local
osteopetrosis and bony osteophytes.
AQP-1 is a 28 kDawater channel formed by six transmem-
brane domains with N- and C-terminus at the inner cytosolic
site of the cell membrane32. Aquaporins are involved inmany
physiological processes, in which the homeostasis of water
content is essential. In contrast, dysregulation and/or clear-
ance of water can become a critical factor as seen in different
human diseases. AQP-1 itself was reported to be selectively
down-regulated in salivary glands in primary Sjo¨gren’s syn-
drome33. With respect to joint physiology, AQP-1 was previ-
ously described to be expressed in articular cartilage when
a systematic investigation of AQP-1 expression in normal hu-
man tissues using tissue microarray technology was per-
formed34. Speciﬁcally, a moderate expression of AQP-1
was observed, which was limited to the deeper zone of artic-
ular cartilage adjacent to the subchondral bone. Most inter-
estingly, as demonstrated in our experiments, expression
of the AQP-1 in OA is not restricted to the deeper zone. In-
creased staining was also seen toward the surface and
even more prominent at the sites of superﬁcial damage com-
pared to unaffected cartilage sections. Expression of AQP-1
in cartilage might depend on the underlying disease. In RA,
AQP-1 could be restricted to chondrocytes located in the
deep zone of articular cartilage, but was also suggested to
be found in synoviocytes and in synovial microvasculature35.
In summary, it can be speculated that the expression of AQP-
1 contributes to the altering of the water-dependent
homeostasis of cells and matrix, a key process in the patho-
physiology of early OA.
At present, there are no data addressing the role of
DNER in OA. DNER is a transmembrane protein expressed
speciﬁcally in cells of the developing and mature central
nervous system36. Interestingly, DNER binds to Notch-1
at cellecell contacts and activates Notch signaling in vitro.
It is well established that notch family proteins control cell
fate and proliferation37. In another murine model, Notch-1
was involved in the complex interactions during ossiﬁcation
and elongation of the growth plate, in which Notch-1 was re-
stricted to hypertrophic chondrocytes38. This work also re-
vealed the expression of Notch-1 by murine articular
cartilage, in which its signaling was suggested to determine
the proliferation of chondrocytes. As EGF domains repre-
sent an important role in the function of cartilage proteogly-
cans, DNER might contribute to the insufﬁcient attempt of
matrix remodeling in OA.
DAF and IF (conglutinogen-activating factor) belong to
the complement system. DAF, also known as CD55, is
a regulatory cell surface protein that protects cells from
complement-mediated lysis. It can bind C3b and C4b and
dissociate the C3 convertase of both the classical and alter-
native pathways39. Aside CD46 and CD59, DAF was found
to be expressed in diseased cartilage from arthritic human
and porcine joints and to be up-regulated when compared
to normal cartilage40. It was hypothesized that complement
regulatory proteins may contribute to ameliorate the damag-
ing effects seen in joint destruction40. However, DAF is ex-
pressed in the synovial lining layer in both rheumatoid
arthritis (RA) and OA as well as on synovial vascular endo-
thelial cells41.
So far, no data exist about the complement C3b
inactivator IF in OA. Unlike DAF, it appears not mem-
brane-associated.
Apart from the genes up-regulated in all ﬁve patients and
discussed above, it is also of interest that in 4/5 patients an
up-regulation of collagen type I was observed, since collagentype I was one of the ﬁrst described matrix molecules to be
induced in human osteoarthritic cartilages42. Together with
periostin, which might contribute to the formation of bony os-
teophytes and which was also reported to play amajor role in
improving the cardiac function after myocardial infarction by
inducing proliferation of differentiated cardiomyocytes43, the
results oncemore indicate the attempt of the chondrocytes to
remodel their extracellular matrix.
In summary, we established a novel approach to identify
genes expressed differentially between intact and damaged
articular cartilages of the same joint in OA patients. This ap-
proach is based on an improved novel mill-based method
for the isolation of sufﬁcient amounts of high-quality RNA
suitable for use in high-density microarray technology. In
this regard, we were able to perform whole-transcriptome
screens by using a chip type comprising probe sets for ap-
proximately 47,400 transcripts and variants, of which
38,500 are well characterized genes. Compared to previ-
ously published work9, our hybridization data contain an ad-
ditional number of 9921 probe sets for 6500 new genes not
detectable by earlier chip versions. Of the 411 transcripts
found to be differentially expressed, we could identify six
genes that were up-regulated in all patients. Of these, spe-
ciﬁcally WISP-1, AQP-1 and DNER could be identiﬁed as
novel target molecules and potential biomarkers44 involved
in the pathogenesis of OA.Conﬂict of interest
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